Status:

UNKNOWN

The Effect of Lavender Oil Inhalation on Pain, Anxiety and Sleep Quality After Coronary Artery Bypass Graft

Lead Sponsor:

Marmara University

Conditions:

Coronary Artery Bypass Graft Surgery

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Cardiovascular diseases are among the important health problems due to their increasing frequency and extensity in developed and developing countries. The most common method of treating cardiovascular...

Detailed Description

The study is a non-drug clinical, randomized controlled study, and will be conducted in the Cardiovascular Surgery Clinic of Bakırköy Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi associated to Istanbu...

Eligibility Criteria

Inclusion

  • The inclusion criteria for the study were determined as follows:
  • 18 years of age or older,
  • undergoing elective CABG surgery,
  • negative lavender oil allergy test,
  • being conscious and oriented to place, person, and time,
  • not having any disability that would make communication difficult,
  • being able to communicate in Turkish, and
  • giving informed written consent to participate in the study.

Exclusion

  • The exclusion criteria for the study were determined as follows:
  • diagnosed with a sleep disorder or using any pharmacological and/or herbal medicine for insomnia,
  • being allergic to lavender, cosmetics, or perfume,
  • having a history of dermatitis,
  • sinusitis,
  • upper respiratory tract infection,
  • liver and kidney dysfunction,
  • asthma, and
  • chronic obstructive pulmonary disease,
  • not having regulated blood pressure,
  • having arrhythmia,
  • using patient-controlled analgesia after surgery,
  • not being able to communicate in Turkish.
  • The remaining exclusion criteria were determined as follows:
  • a positive lavender oil allergy test,
  • development of lavender allergy during the study,
  • voluntarily deciding to leave the study, and
  • not complying with the study process and conditions.

Key Trial Info

Start Date :

June 17 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 24 2023

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT05377983

Start Date

June 17 2021

End Date

August 24 2023

Last Update

May 17 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Yesim Dikmen Aydin

Maltepe, Istanbul, Turkey (Türkiye), 34854